Ligand Pharmaceuticals Inc (LGND)

150.23 +1.35  +0.91% NASDAQ Apr 16, 20:00 USD
View Full Chart
Price Chart
View All LGND News

News

View All Events

Events

Date Type Description
05/06/2020 00:00 Earnings Results Q1 2020 Earnings Results
05/06/2020 00:00 EDT Earnings Calls Q1 2020 Earnings Call
06/10/2020 08:30 PDT Agm 2019 Annual General Meeting
08/03/2020 08:30 EDT Earnings Calls Q2 2020 Earnings Call
08/03/2020 00:00 Earnings Results Q2 2020 Earnings Results
10/30/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/30/2020 08:30 EDT Earnings Calls Q3 2020 Earnings Call
02/03/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/03/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
05/06/2021 00:00 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
  • URL: http://www.ligand.com
  • Investor Relations URL: https://investor.ligand.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: May. 06, 2021
  • Last Earnings Release: Feb. 03, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Jul. 02, 2010

Top Fund Holders

Symbol Name Weighting
BBP Virtus LifeSci Biotech Products ETF 3.17%
PJP Invesco Dynamic Pharmaceuticals ETF 2.95%
PXSAX Pax Small Cap A 2.69%
SBIO ALPS Medical Breakthroughs ETF 1.80%
IDNA iShares Genomics Immnlgy & Hlthcr ETF 1.79%
WSMNX William Blair Small-Mid Cap Gr N 1.72%
VEVFX Vanguard Explorer Value Inv 1.67%
BUISX Buffalo Small Cap Institutional 1.63%
BUITX Buffalo Discovery Institutional 1.56%
WBSNX William Blair Small Cap Growth N 1.45%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.